US Patent Issued to Medtronic on April 8 for "Latency-based adaptation of anti-tachyarrhythmia pacing therapy" (Minnesota Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,881, issued on April 8, was assigned to Medtronic Inc. (Minneapolis).

"Latency-based adaptation of anti-tachyarrhythmia pacing therapy" was invented by Troy E. Jackson (Rogers, Minn.) and Vincent P. Ganion (Blaine, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A medical device comprises therapy delivery circuitry and processing circuitry. The therapy delivery circuitry is configured to deliver anti-tachycardia pacing (ATP) therapy to a heart of a patient. The ATP therapy includes one or more pulse trains and each of the one or more pulse trains includes a plurality of pacing pulses. The processing circuitry is configured to, for at least one ...